Skip to content
AnalystLens

Idex 8-K Report, Financial Results (Jul 30, 2025)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed July 30, 2025
Period End
July 30, 2025
Security
IEX
In the record · 2016–202610-K1110-Q338-K119

IEX filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 119 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Jan ’18Jan ’18
  2. Material agreement8-K · Apr ’20Apr ’20
  3. Leadership change8-K · Sep ’22Sep ’22
  4. Material agreement8-K · Sep ’26Sep ’26

Summary

Summary of the 8-K filed July 30, 2025. Cited figures are marked; the original filing is the authoritative source.

IDEX Corporation reported second-quarter 2025 results for the period ended June 30, 2025, with record net sales of $865.4 milliona, up 7% on a reported basis and 1% organically.

Reported diluted EPS was $1.74b, down from $1.86 a year earlier, while adjusted diluted EPS was $2.07, essentially flat versus $2.06. Orders were $829.8 million, up 7% reported and 2% organically, which management described as below the year-to-date average. Net sales growth was driven mainly by the Mott Corporation acquisition, while organic growth reflected positive price and targeted growth initiatives, partly offset by lower volumes in the Fluid & Metering Technologies segment.

Management lowered its full-year 2025 outlook to GAAP diluted EPS of $6.30 to $6.44c and adjusted diluted EPS of $7.85 to $7.95, down from prior guidance of $6.56 to $6.95 and $8.10 to $8.45 respectively, based on expected full-year organic sales growth of approximately 1%. The CEO attributed the reset to a downshift in rapid-turn order trends exiting the quarter and customers taking a more cautious stance on larger orders, which delayed expected second-half acceleration in recently acquired businesses. For the third quarter, the company guided to GAAP diluted EPS of $1.54 to $1.61 and adjusted diluted EPS of $1.90 to $1.95, with organic sales growth of 2% to 3%.

Cash generation improved, with operating cash flow of $161.7 milliond in the quarter, up from $133.6 million, and free cash flow of $146.9 million, up from $117.7 million. During the period the company repurchased 268,586 shares for $50.0 million in May 2025 and repaid $100.0 million of 3.37% Senior Notes in June 2025. In July 2025 it acquired Micro-LAM, Inc. for $90.0 million in cash plus a potential earnout of up to $12.0 million.

Key Highlights

  1. Record second-quarter net sales of $865.4 million, up 7% reported and 1% organically, with growth largely driven by the Mott acquisition.
  2. Reported diluted EPS fell to $1.74 from $1.86, while adjusted diluted EPS was $2.07 versus $2.06, roughly flat.
  3. Orders of $829.8 million rose 7% reported and 2% organically, below the year-to-date average according to the filing.
  4. Full-year 2025 GAAP diluted EPS guidance was lowered to $6.30–$6.44 from $6.56–$6.95, and adjusted diluted EPS guidance to $7.85–$7.95 from $8.10–$8.45.
  5. Third-quarter 2025 guidance calls for GAAP diluted EPS of $1.54–$1.61 and organic sales growth of 2% to 3%.
  6. Free cash flow rose to $146.9 million from $117.7 million, helped by favorable working capital primarily from timing of collections.
  7. Capital returned and deployed: $50.0 million of share repurchases in May, $100.0 million Senior Notes repaid in June, and the $90.0 million cash acquisition of Micro-LAM in July.

Frequently Asked Questions

  1. Why did IDEX lower its full-year 2025 earnings outlook?

    Management said order trends in its rapid-turn businesses downshifted slightly exiting the second quarter, and customers were taking a more cautious stance on larger orders in an uncertain macro environment. This delayed the expected second-half acceleration in parts of its recently acquired businesses, leading management to reset its baseline assumptions for the rest of 2025.

  2. How did IDEX's segments perform in the second quarter?

    Health & Science Technologies net sales rose 20% to $365.3 million, driven by the Mott acquisition, with organic sales up 4%. Fluid & Metering Technologies net sales fell 3% to $310.9 million, with organic sales down 2% on lower volumes, while Fire & Safety/Diversified Products net sales increased 3% to $191.5 million, with organic sales up 2%.

  3. Why did reported diluted EPS decline while adjusted EPS was flat?

    The filing attributes the gap to higher interest expense from debt raised for the 2024 Mott acquisition, higher depreciation, and a higher effective tax rate. GAAP results also include higher acquisition-related amortization and the absence of a prior-year gain on the Alfa Valvole divestiture, which are excluded from adjusted EPS, and the prior year benefited more from discrete one-time tax items.

  4. What is the outlook for cash flow and capital deployment?

    Operating cash flow and free cash flow both increased in the second quarter, with free cash flow conversion of 94% compared with 75% a year earlier. The company also repurchased $50.0 million of stock, repaid $100.0 million of 3.37% Senior Notes, and acquired Micro-LAM for $90.0 million in cash plus a potential earnout of up to $12.0 million.